Alpha Teknova (TKNO) Competitors

Amphastar Pharmaceuticals (NASDAQ:AMPH) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership and profitability.

Does the media favor AMPH or TKNO?

In the previous week, Amphastar Pharmaceuticals had 3 more articles in the media than Alpha Teknova. MarketBeat recorded 7 mentions for Amphastar Pharmaceuticals and 4 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 0.63 beat Amphastar Pharmaceuticals' score of 0.38 indicating that Alpha Teknova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Amphastar Pharmaceuticals	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alpha Teknova	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is AMPH or TKNO more profitable?

Amphastar Pharmaceuticals has a net margin of 19.38% compared to Alpha Teknova's net margin of -60.90%. Amphastar Pharmaceuticals' return on equity of 22.20% beat Alpha Teknova's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amphastar Pharmaceuticals	19.38%	22.20%	10.40%
Alpha Teknova	-60.90%	-28.48%	-19.73%

Which has better earnings & valuation, AMPH or TKNO?

Amphastar Pharmaceuticals has higher revenue and earnings than Alpha Teknova. Alpha Teknova is trading at a lower price-to-earnings ratio than Amphastar Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amphastar Pharmaceuticals	$731.97M	1.49	$159.52M	$2.76	8.40
Alpha Teknova	$37.74M	7.39	-$26.75M	-$0.48	-10.88

Do institutionals and insiders hold more shares of AMPH or TKNO?

65.1% of Amphastar Pharmaceuticals shares are held by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are held by institutional investors. 27.5% of Amphastar Pharmaceuticals shares are held by company insiders. Comparatively, 12.5% of Alpha Teknova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Do analysts prefer AMPH or TKNO?

Amphastar Pharmaceuticals currently has a consensus price target of $32.33, indicating a potential upside of 39.52%. Alpha Teknova has a consensus price target of $8.50, indicating a potential upside of 62.84%. Given Alpha Teknova's stronger consensus rating and higher probable upside, analysts plainly believe Alpha Teknova is more favorable than Amphastar Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amphastar Pharmaceuticals	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
Alpha Teknova	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more volatility and risk, AMPH or TKNO?

Amphastar Pharmaceuticals has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500. Comparatively, Alpha Teknova has a beta of 0.33, meaning that its share price is 67% less volatile than the S&P 500.

Summary

Amphastar Pharmaceuticals beats Alpha Teknova on 11 of the 16 factors compared between the two stocks.